Knight Therapeutics | GUD - El Costo De Ventas

Precio De Mercado
7.55
Cambio Diario
-0.10 -1.31%
Mensual
21.97%
Anual
35.06%
Q2 Expectativa
7.26




El Costo De Ventas Cambio Fecha
Akebia Therapeutics USD 10.34M 441K 2025-12
Alaunos Therapeutics USD 0 18K 2024-09
Aurora Cannabis CAD 88.61M 30.53M 2025-12
Avita Medical AUD 3.3M 166K 2025-12
Canopy Growth CAD 53.08M 8.3M 2025-12
Cronos Group USD 28.74M 10.38M 2025-12
Ionis Pharmaceuticals USD 8M 5.66M 2025-12
IQVIA Holdings USD 3.24B 518M 2025-12
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Moderna USD 452M 245M 2025-12
Omeros USD 33.16M 18.52M 2024-06
Organigram Holdings CAD 56.93M 20.53M 2025-12
Organon & Co USD 745M 25M 2025-09
Revvity USD 350.4M 26.05M 2025-12
Tilray USD 164.37M 8.41M 2025-09
Viatris USD 2.56B 167.3M 2025-12
Xeris Pharmaceuticals USD 13.66M 49K 2025-12